Cost-effectiveness of group psychotherapy for depression in Uganda

Journal of Mental Health Policy and Economics

Volumn 11, Issue 3, 2008, Pages 127-133

  Siskind, Dan ^a   Baingana, Florence ^b   Kim, Jane ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DEPRESSION; DEVELOPING COUNTRY; ECONOMIC EVALUATION; GROUP THERAPY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; LOWEST INCOME GROUP; MENTAL HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RECURRENCE RISK; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; UGANDA;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DEPRESSION; HUMANS; MARKOV CHAINS; PSYCHOTHERAPY, GROUP; QUALITY-ADJUSTED LIFE YEARS; UGANDA;

EID: 51049106608     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ustun TB, Ayuso-Mateos J L, Chatterji S, Mathers C, and Murray C J. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
2. Mulrow CD, Williams J W Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, and Stamm K. Efficacy of newer medications for treating depression in primary care patients. Am J Med 2000; 108: 54-64.
3. Rush A J, Trivedi M H, Wisniewski S R, Nierenberg A A, Stewart J W, Warden D, Niederehe G, ThaseME, Lavori PW, Lebowitz B D, McGrath P J, Rosenbaum J F, Sackeim H A, Kupfer D J, Luther J and Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006: 163: 1905-1917.
4. Casacalenda N, Perry J C, and Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 2002; 159: 1354-60.
5. Luty SE, Carter JD, McKenzie JM, Rae AM, Frampton CM, Mulder R T, and Joyce PR. Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry 2007; 190: 496-502.
6. Saxena S, Thornicroft G, Knapp M and Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 2007; 370: 878-889.
7. Towse A, Mills A, and Tangcharoensathien V. Learning from Thailand's health reforms. BMJ 2004; 328: 103-5.
8. Bolton P, Bass J, Neugebauer R, Verdeli H, Clougherty KF, Wickramaratne P, Speelman L, Ndogoni L, and Weissman M. Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. JAMA 2003; 289: 3117-3124.
9. Bass J, Neugebauer R, Clougherty KF, Verdeli H, Wickramaratne P, Ndogoni L, Speelman L, Weissman M, and Bolton P. Group interpersonal psychotherapy for depression in rural Uganda: 6-month outcomes: randomised controlled trial. Br J Psychiatry 2006; 188: 567-573.
10. Chisholm D, Sanderson K, Ayuso-Mateos JL, and Saxena S. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004; 184: 393-403.
11. Eaton WW, Kramer M, Anthony JC, Dryman A, Shapiro S, and Locke BZ. The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand 1989; 79: 163-178.
12. Solomon DA, Keller MB, Leon A C, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, and Endicott J. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157: 229-233.
13. Mahapatra P, Salomon JA, and Nanda L. Measuring health state values in developing countries: Results from a community sruvey in Andhra Pradesh. In C.J.L. Murray (ed).Summary of Measures of Population Health: Concepts, Ethics, Measurement and Applications. Geneva: WHO, 2002.
14. Mathers C D et al. Estimates of healthy life expectancy for 191 countries in the year 2000: methods and results. GPE Discussion Paper No. 38. Geneva: WHO, 2000.
15. Goldney R D, Dal Grande E, Fisher L J, and Wilson D. Population attributable risk of major depression for suicidal ideation in a random and representative community sample. J Affect Disord 2003; 74: 267-272.
16. Burrows S and Laflamme L. Suicide mortality in South Affica: a city-level comparison across socio-demographic groups. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 108-114.
17. Burrows S, Vaez M, and Laflamme L. Sex-specific suicide mortality in the South African urban context: the role of age, race, and geographical location. Scand J Public Health 2007; 35: 133-139.
18. Harris, EC and Barraclough, B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228.
19. Isacsson G, Bergman U, and Rich CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996; 41: 1-8.
20. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, and Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097-1103.
21. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP.et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989; 46: 971-982.
22. Ellis P. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry 2004; 38: 389-407.
23. Frank E, Kupfer DJ, Buysse DJ, Swartz HA, Pilkonis PA, Houck PR, Rucci P, Novick DM, Grochocinski VJ, and Stapf DM. Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. Am J Psychiatry 2007; 164: 761-767.
24. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds). Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
25. World Health Organization. WHO CHOICE (Choosing Interventions That Are Cost-Effective). [cited 2007 January 19, 2007]; Available from: http://www.who.int/choice/en/.
26. World Development Indicators. 3 April 2008 [cited; Available from: http://publications.worldbank.org/WDI/.
27. WHO Commission on Macroeconomics and Health. [cited 19 July 2007]; Available from: http://www.who.int/macrohealth/en/.
28. CIA World Factbook. [cited 19 July 2007]; Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/ci.html.
29. Gaziano TA, Opie LH, and Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006; 368: 679-686.
30. Narayan K M V (Ed). Diabetes: The Pandemic and Potential Solutions. New York Washington, DC: Oxford University Press; World Bank, 2006.
31. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein M C, Anglaret X, Walensky R P, Hsu H E, Kimmel A, Holmes C, Kaplan JE, and Freedberg K A. Cost-effectiveness of HIV treatment in resource-poor settings-the case of Cote d'Ivoire. N Engl J Med 2006; 355: 1141-1153.
32. Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, De Silva M, Hosman C, McGuire H, Rojas G, and van Ommeren M. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 2007; 370: 991-1005.
33. da Silva Lima AF and de Almeida Fleck MP. Subsyndromal depression: an impact on quality of life? J Affect Disord 2007; 100: 163-169.
34. Joynt KE, Whellan DJ, and O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003; 54: 248-61.
35. Kleinman A. Culture and depression. N Engl J Med 2004; 351: 951-953.